Funding Events for Vertical: Biopharmaceuticals
← Back to All Verticals| Parabilis Medicines | Series F | January 12, 2026 | Biopharmaceuticals |
| AeroRx Therapeutics | Series A | October 7, 2025 | Biopharmaceuticals |
| Crystalys Therapeutics | Series A | October 6, 2025 | Biopharmaceuticals |
| LPOXY Therapeutics | Series A | September 3, 2025 | Biopharmaceuticals |
| Pharvaris N.V. | Public Offering | August 14, 2025 | Biopharmaceuticals |
| Retension Pharmaceuticals | Series B | August 6, 2025 | Biopharmaceuticals |
| Retension Pharmaceuticals | Series B | August 6, 2025 | Biopharmaceuticals |
| Renasant Bio | Seed | July 14, 2025 | Biopharmaceuticals |
| Syntis Bio | Series A | July 6, 2025 | Biopharmaceuticals |
| Syntis Bio, Inc. | Series A | July 1, 2025 | Biopharmaceuticals |
| Beech Biotech | Grant | June 27, 2025 | Biopharmaceuticals |
| Pharmazz | Equity | June 13, 2025 | Biopharmaceuticals |
| Seaport Therapeutics | Series B | June 9, 2025 | Biopharmaceuticals |
| Trace Neuroscience | Series A | June 9, 2025 | Biopharmaceuticals |
| Shape Biopharmaceuticals | Grant | June 9, 2025 | Biopharmaceuticals |
| Maze Therapeutics | Series D | June 8, 2025 | Biopharmaceuticals |
| Angitia Biopharmaceuticals | Series C | May 30, 2025 | Biopharmaceuticals |
| Kexing Biopharm | IND Clearance | May 29, 2025 | Biopharmaceuticals |
| Takeda | Grant | May 19, 2025 | Biopharmaceuticals |
| Idorsia | Debt Restructuring | May 18, 2025 | Biopharmaceuticals |
| NLS Pharma | Equity Financing | May 17, 2025 | Biopharmaceuticals |
| Paradigm Therapeutics | Series A | May 16, 2025 | Biopharmaceuticals |
| Lomond Therapeutics | Private Placement Financing | March 28, 2025 | Biopharmaceuticals |
| Montara Therapeutics | Seed | March 13, 2025 | Biopharmaceuticals |
| BioVersys AG | IPO | January 29, 2025 | Biopharmaceuticals |
Showing 1 to 25 of 150 records
Page 1 of 6